However, a recent randomized
controlled trial41 has demonstrated no significant
difference in hemodynamic status between women
given prophylactic intravenous oxytocin by infusion or
by bolus; this study does not address giving intravenous
boluses of oxytocin to women who are already
hemodynamically unstable